fda update on tirzepatide Approves (Zepbound) as the First Medication for Obstructive Sleep Apnea Tirzepatide Compounding Update: FDA Reversal

Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide

By supporting the food-to-energy conversion process, these injections can help individuals stay active and engaged in their exercise routines, which is critical for burning calories and losing weight

And I just want to say that the parallels here, for example, with Kati Karik , my friend who had the Nobel Award for mRNA, she spent three decades trying to get people to listen to her and never got a grant from the NIH or other places [our conversation here]

Alternate between multiple sites to prevent lipohypertrophy (fatty lumps under skin), reduce scar tissue formation, and maintain consistent absorption